DEVICE GUIDE > Embolic Particles/Beads

Company Name Product Name Composition Type Sizes (µm) Color Coding US FDA Indicated Use
Boston Scientific Corporation Contour Embolizaton Particles PVA particles Irregularly shaped flakes 45–150, 150–250, 250–355, 355–500, 500–710, 710–1,000, 1,000–1,180 Labels are color-coded by particle size Embolization of peripheral hepatic vascular tumors, including leiomyoma, uteri, and peripheral AVMs
Boston Scientific Corporation Embozene Microspheres Hydrogel microsphere with Polyzene-F coating Precisely calibrated spherical microspheres 40, 75, 100, 250, 400, 500, 700, 900, 1,100, 1,300 Labels, boxes, and microspheres themselves are color-coded by microsphere size Embolization of AVMs and hypervascular tumors, including hepatoma and uterine fibroid
Boston Scientific Corporation Oncozene Microspheres Hydrogel microsphere with Polyzene-F coating Precisely calibrated spherical microspheres 40, 75, 100 Labels and boxes are color-coded by microsphere size Embolization of AVMs and hypervascular tumors, including hepatoma
BTG International Bead Block Precisely calibrated biocompatible PVA Hydrogel microspheres 100–300, 300–500, 500–700, 700–900, 900–1,199 Syringe labels are color-coded by size: yellow, blue, red, green, purple Embolization of hypervascularized tumors and AVMs
BTG International LC Bead Precisely calibrated biocompatible PVA Hydrogel microspheres 100–300, 300–500, 500–700, 700–900, 900–1,200 Vial labels are color-coded by size: yellow, blue, red, green, purple Embolization of hypervascularized tumors and AVMs
BTG International LC Bead LUMI Precisely calibrated, radiopaque, biocompatible PVA Hydrogel microspheres 70–150, 100–300 Vial labels are color-coded by size: black and yellow Embolization of hypervascular tumors and AVMs
BTG International LC Bead M1 Precisely calibrated biocompatible PVA Hydrogel microspheres 70–150 Vial label is black Embolization of hypervascularized tumors and AVMs
Cook Medical PVA Foam Embolization Particles PVA particles Irregularly shaped particles 90–180, 180–300, 300–500, 500–710, 710–1,000 Vial labels and tops are color-coded by particle size Embolization of the blood supply to hypervascular tumors, and AVMs, including use in intracranial embolization
Merit Medical Systems, Inc. Bearing nsPVA Embolization Particles PVA particles Irregularly shaped particles 45–150, 150–250, 250–355, 355–500, 500–710, 710–1,000, 1,000–1,180 Labels are color-coded by particle size Indicated for the embolization of AVMs and hypervascular tumors, including symptomatic uterine fibroids
Merit Medical Systems, Inc. EmboGold Microspheres Trisacryl with gelatin Colored spherical embolic microspheres 40–120, 100–300, 300–500, 500–700, 700–900, 900–1,200 Labels are color-coded by particle size Indicated for the embolization of hypervascularized tumors and AVMs
Merit Medical Systems, Inc. Embosphere Microspheres Trisacryl with gelatin Spherical embolic microspheres 40–120, 100–300, 300–500, 500–700, 700–900, 900–1,200 Labels are color-coded by particle size Indicated for the embolization of AVMs, hypervascular tumors, and symptomatic uterine fibroids
Merit Medical Systems, Inc. QuadraSphere Microspheres Sodium acrylate alcohol copolymer Spherical embolic microspheres 30–60 (120–240 reconstituted), 50–100 (200–400 reconstituted), 100–150 (400–600 reconstituted), 150–200 (600–800 reconstituted) Labels are color-coded by particle size Indicated for the embolization of hypervascularized tumors, including hepatoma, and peripheral AVMs

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.